Saturday 17 October 2026 Export AAPG’s income statement to Excel — free account

Ascentage Pharma Group International - Unsponsored ADR

Ascentage Pharma Group International - Unsponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $82.1 million, down 38.9% from fiscal 2024.

15.37 0.68 +4.63%

Follow AAPG

Alert me

Market cap: $1.4B
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: 3/9
Altman Z: 0.81
Beneish M: 0.58
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+2 more TTM periods Free account	—	—	0.00%	0.00%
ROA Full definition →		—	—	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		—	—	0.00	0.00
Free Cash Flow Full definition →		—	—	(347.72)	(328.87)
Capital Expenditures Full definition →		—	—	(15.89)	(11.29)
Other line items
Cash ROIC Full definition →		0.00%	0.00%	(42.04%)	(48.98%)
Accounts Receivable Turnover Full definition →		—	—	0.00	0.00
Accounts Payable Turnover Full definition →		—	—	0.00	0.00
Inventory Turnover Full definition →		—	—	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		—	—	0.00	0.00
Depreciation/Fixed assets Full definition →		0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →		—	—	0.00	0.00
Operating CF per Share Full definition →		—	—	0.00	0.00
Capex per Share Full definition →		—	—	0.00	0.00
Capex to Sales Full definition →		—	—	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly